Immune composition comprising respiratory syncytial virus (RSV) G polypeptide
Immune compositions comprising (i) a respiratory syncytial virus (RSV) G polypeptide, which may be a modified G polypeptide relative to the wild-type counterpart, or a nucleic acid encoding such, and (ii) a solvent and one or more immune regulators, wherein the immune regulator(s) is dissolvable in...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English |
Published |
06.06.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Immune compositions comprising (i) a respiratory syncytial virus (RSV) G polypeptide, which may be a modified G polypeptide relative to the wild-type counterpart, or a nucleic acid encoding such, and (ii) a solvent and one or more immune regulators, wherein the immune regulator(s) is dissolvable in the solvent. Also provided herein are methods for eliciting anti-RSV immune responses using the immune compositions disclosed herein and methods for producing the immune compositions. |
---|---|
Bibliography: | Application Number: US202016985736 |